BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11068644)

  • 1. Lipoproteins and vascular changes in chronic kidney failure.
    Wanner C
    Adv Nephrol Necker Hosp; 2000; 30():215-20. PubMed ID: 11068644
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction, atherosclerosis and thrombosis in uremia--possibilities of intervention.
    Myśliwiec M; Borawski J; Naumnik B; Rydzewska-Rosołowska A
    Rocz Akad Med Bialymst; 2004; 49():151-6. PubMed ID: 15631332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic renal failure and atherogenesis. Influence of serum factors on prostaglandin synthesis in endothelial cells.
    Bauch HJ; Vischer P; Lauen A; Raidt H; Graefe U; Hauss WH
    Prog Clin Biol Res; 1989; 301():383-8. PubMed ID: 2798453
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of lipoproteins on signal transduction in thrombocytes and vascular wall cells].
    Bochkov VN; Tkachuk VA
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):12-30. PubMed ID: 15773577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies of atherogenic lipoproteins in hemodialysis patients: do they tell us more about their pathology?
    Kronenberg F; Ikewaki K; Schaefer JR; König P; Dieplinger H
    Semin Dial; 2007; 20(6):554-60. PubMed ID: 17991204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does carotid-ankle vascular index reflect proper vascular distensibility in hemodialysis patients?
    Matsumae T; Ueda K
    Hypertens Res; 2009 Aug; 32(8):641-2. PubMed ID: 19575015
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation.
    Galle J; Wanner C
    Miner Electrolyte Metab; 1999; 25(4-6):263-8. PubMed ID: 10681650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of aldosterone in ESRD: Part II.
    Diskin CJ; Stokes TJ; Dansby LM; Carter TB; Radcliff L
    Nephrol Dial Transplant; 2004 May; 19(5):1331-2; author reply 1332. PubMed ID: 15102982
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular changes in chronic renal failure--pathogenesis and therapy.
    Amann K; Tyralla K
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S62-72. PubMed ID: 12227729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelial dysfunction in chronic renal failure].
    Cases A; Bragulat E; Serradell M; Vera M; de la Sierra A; Escolar G
    Nefrologia; 2003; 23 Suppl 4():42-51. PubMed ID: 14626813
    [No Abstract]   [Full Text] [Related]  

  • 15. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid disorders in chronic renal failure].
    Ducobu J; Dupont P; Hainaut J
    Rev Med Brux; 1983 Feb; 4(2):75-9. PubMed ID: 6342083
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular risk in end-stage renal disease: vascular aspects.
    London GM; Marchais SJ; Metivier F; Guerin AP
    Nephrol Dial Transplant; 2000; 15 Suppl 5():97-104. PubMed ID: 11073281
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein(a). Thrombogenesis linked to atherogenesis at last?
    Scott J
    Nature; 1989 Sep; 341(6237):22-3. PubMed ID: 2528074
    [No Abstract]   [Full Text] [Related]  

  • 19. Do vascular wall cytokines promote atherogenesis?
    Libby P
    Hosp Pract (Off Ed); 1992 Oct; 27(10):51-8. PubMed ID: 1400673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence on hazelnut oil administration on peroxidation status of erythrocytes and apolipoprotein B 100-containing lipoproteins in rabbits fed on a high cholesterol diet.
    Balkan J; Hatipoğlu A; Aykaç-Toker G; Uysal M
    J Agric Food Chem; 2003 Jun; 51(13):3905-9. PubMed ID: 12797764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.